VK-2019
VK-2019-001
Phase 2 small_molecule terminated
Quick answer
VK-2019 for Nasopharyngeal Carcinoma is a Phase 2 program (small_molecule) at Cullinan Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cullinan Therapeutics
- Indication
- Nasopharyngeal Carcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated